Ultima Genomics

Ultima Genomics is unleashing the power of genomics at scale. The Company’s mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biology’s complexity and dynamic change—and a further need to challenge conventional next-generation sequencing technologies. Ultima’s revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information. The new sequencing architecture was designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information and catalyze the next phase of genomics in the 21st century.
Active
October 2016
313
Hardware, Software
B2B

people
Avishai Bartov
VP GM
AI Expert

people
Jory Bell
Board Member
people
Scott Kupor
Managing Partner
people
Todd Stone
General Partner a…
people
Victoria Sun
Principal and Boa…

$600,000,000

September 1, 2019
Series A

Date Announced

Round Stage

Round Size

Lead Investors

December 1, 2018
Seed
aMoon

Date Announced

Round Stage

Round Size

Lead Investors

amoon
aMoon
Venture Capital
2016
$1,000,000,000

Investor

Investor Type

Founded

Funds Raised

andreessen-horowitz-logo
Andreessen Horowitz
Venture Capital
2009
$10,000,000,000

Investor

Investor Type

Founded

Funds Raised

investor
D1 Capital
2018

Investor

Investor Type

Founded

Funds Raised

Machine Learning

Register Pro to view more

Pro

$50 per month

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database

Select a Table to Export